Stock screenerAll disclosures →
EDGAR →
GRML
Conviction 0HealthcareScan · Mon, Aug 10, 2026GRML$0.2030+4.64%
ResistanceSupportVol 14Insider buyVol MA14 4.4M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.2030
Change+4.64%
Gap-0.36%
Rel volume0.11×
Avg volume8.93M
Avg $ vol1.8M
SMA 200.1963
SMA 500.2464
SMA 200—
Price vs 50-17.61%
Price vs 200—
MA stack—
50/200 cross—
Supertrenddown · 0.2660
RSI (14)47
MACD hist0.00
MACD cross—
Stoch %K / %D24 / 17
ADX (14)16
+DI / −DI19 / 17
RSI divergence—
MACD divergence—
ATR %+14.10%
ADR %16.21%
52w high0.5156
52w low0.1739
From 52w high-60.63%
Above 52w low+16.73%
New 52w highNo
SqueezeOn · 13d
Bollinger width31.25%
%B0.61
Donchian pos33.19%
Donchian high0.2970
Donchian low0.1563
AVWAP (52w high)0.2657
vs AVWAP high-23.59%
AVWAP (52w low)0.2034
vs AVWAP low-0.19%
OBV trendFlat
Chaikin MF (20)0.02
Today vs 20d0.11×
Avg vol (14d)4.4M
Avg vol (20d)8.93M
Avg $ vol (20d)1.8M
Market cap24.61M
RS 3m (vs SPY)-66.66%
RS 6m (vs SPY)—
RS line new highNo
Trend template—
Technical rank26.0
1 week+0.94%
1 month-17.11%
3 months-55.88%
6 months—
1 year—
YTD-56.62%
P/E-2.33
P/B0.48
P/S—
P/FCF—
EPS-0.2200
Div yield—
ROE-20.50%
ROA-17.66%
Debt/Eq0.01
Current19.74
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-71.56%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value14.91M
Revenue—
Net income-13.86M
Gross profit—
Free cash flow—
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out121.24M
Employees5
ListedThu, Mar 12, 2026
Free float100.83M
Float %83.2%
Short interest7.89M
Days to cover2.1d
Short volume19.1%
Squeeze score26 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank26.0 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.3181
Support0.1644
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GRML
No recent disclosed trades by Congress in GRML. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in GRML · 1 buy
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
LeBlanc Jeff Chief Financial Officer · Common Stock · 2026-07-16 | Buy | 1.4M | $245K | 2026-07-16 | 2026-07-17 |
SEC filings
EDGAR filings in GRML · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.